Journal article
Randomized interventional study on prediction of preeclampsia/eclampsia in women with suspected preeclampsia
- Abstract:
-
The ratio of maternal serum sFlt-1 (soluble fms-like tyrosine kinase 1) to PlGF (placental growth factor) has been used retrospectively to rule out the occurrence of preeclampsia, a pregnancy hypertensive disorder, within 7 days in women presenting with clinical suspicion of preeclampsia. A prospective, interventional, parallel-group, randomized clinical trial evaluated the use of sFlt-1/PlGF ratio in women presenting with suspected preeclampsia. Women were assigned to reveal (sFlt-1/PlGF res...
Expand abstract
- Publication status:
- Published
- Peer review status:
- Peer reviewed
Actions
Access Document
- Files:
-
-
(Version of record, pdf, 393.7KB)
-
- Publisher copy:
- 10.1161/HYPERTENSIONAHA.119.12739
Authors
Bibliographic Details
- Publisher:
- American Heart Association Publisher's website
- Journal:
- Hypertension
- Volume:
- 74
- Issue:
- 4
- Pages:
- 983-990
- Publication date:
- 2019-08-12
- Acceptance date:
- 2019-06-12
- DOI:
- EISSN:
-
1524-4563
- ISSN:
-
0194-911X
- Pmid:
-
31401877
- Source identifiers:
-
1046229
Item Description
- Language:
- English
- Keywords:
- Pubs id:
-
pubs:1046229
- UUID:
-
uuid:3a2b2996-1c5b-4498-b61d-222470b9ec75
- Local pid:
- pubs:1046229
- Deposit date:
- 2019-09-05
Terms of use
- Copyright date:
- 2019
- Notes:
- © 2019 The Authors. Hypertension is published on behalf of the American Heart Association, Inc., by Wolters Kluwer Health, Inc. This is an open access article under the terms of the Creative Commons Attribution Non-Commercial-NoDerivs License, which permits use, distribution, and reproduction in any medium, provided that the original work is properly cited, the use is noncommercial, and no modifications or adaptations are made.
If you are the owner of this record, you can report an update to it here: Report update to this record